Standard resection and lymhadenectomy in gastric cancer;Standardresektion und lymphadenektomie beim magenkarzinom

Chirurgische Gastroenterologie mit Interdisziplinaren Gesprachen

Volumn 15, Issue 3, 1999, Pages 227-236

  Lehnert, T ^a   Kienle, P ^b   Maksan, S ^b   Herfarth, C ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b NONE

Author keywords

Gastric cancer; Lymphadenectomy (randomized trials)

Indexed keywords

ARTICLE; ASIA; CANCER CENTER; CLINICAL TRIAL; EUROPE; GASTRECTOMY; HUMAN; LYMPHADENECTOMY; MORBIDITY; MORTALITY; POSTOPERATIVE COMPLICATION; SOUTH AFRICA; STOMACH CANCER;

EID: 0032875006     PISSN: 01779990     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012562     Document Type: Article

References (58)

1. Sipponen P, Järvi O, Kekki M, Siurala M: Decreased incidences of intestinal and diffuse types of gastric cancer. Scand J Gastroenterol 1987; 22:865-871.
2. Karpeh MS, Brennan MF: Gastric carcinoma. Ann Surg Oncol 1998;5:650-656.
3. McCulloch P: Should general surgeons treat gastric carcinoma? An audit of practice and results, 1980-1985. Br J Surg 1994;81:417-420.
4. Hermanek P: Prognostic factors in stomach cancer surgery. Eur J Surg Oncol 1986;12:241-246.
5. Böttcher K, Siewert JR, Roder J, Busch R, Hermanek P, Meyer HJ: Risiko der chirurgischen Therapie des Magencarcinoms. Chirurg 1994; 65:298-306.
6. Roder J, Böttcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ: Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study. Cancer 1993;72:2089-2097.
7. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJH: Extended lymph-node dissection for gastric cancer. N Engl J Med 1999;340:908-914.
8. Laurén P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal type carcinoma. APMIS 1965;64:31-49.
9. Gabbert HE, Meier S, Gerharz CD, Hommel G: Tumor cell dissociation at the invasive front: A new prognostic parameter in gastric cancer patients. Int J Cancer 1992;50:202-207.
10. Eker R, Efskind J: Investigations on the intramural spread of gastric carcinoma. APMIS 1952;30:371-381.
11. Papachristou DN, Fortner JG: Local recurrence of gastric adenocarcinoma after gastrectomy. J Surg Oncol 1981;18:47-53.
12. Bozzetti F, Bonfanti G, Bufalino R, Menotti V, Persano S, Andreola S, Doci R, Gennari L: Adequacy of margins of resection in gastrectomy for cancer. Ann Surg 1982;196:685-690.
13. Yu CW, Levison DA, Dunn JA, Ward LC, Demonakou M, Allum WH, Allisey MT: Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer. Br J Cancer 1995;71:1106-1110.
14. Haugstvedt TK, Viste A, Eide GE, Maartmann-Moe H, Myking A, Soreide O, and members of the Norwegian Stomach Cancer Trial: Is Laurén's histopathological classification of importance in patients with stomach cancer? A national experience. Eur J Surg Oncol 1992;18:124-130.
15. Hermanek P: Differenziertes chirurgisches Vorgehen bei der kurativen Therapie des Magenkarzinoms. Leber Magen Darm 1996;26:64-72.
16. Hermanek P: Prognostic factors in stomach cancer surgery. Eur J Surg Oncol 1986;12:241-246.
17. Leitlinien zur Therapie des Magencarcinoms: Mitteilungen der Deutschen Gesellschaft für Chirurgie, Beilage G75, Heft 2, 1997.
18. Gentsch HH, Hermanek P, Giedl J: Influence of histopathological findings on choice of surgical therapy and survival in gastric cancer patients; in Klein HO (Hrsg): Chemotherapy for Gastrointestinal Cancer. Erlangen, Perimed, 1984, pp 211-219.
19. Bozzetti F, Bonfanti G, Regalia E, Andreola S, Doci R, LaMalfa G, Gennari L: How long is a 6 cm margin of resection in the stomach. Eur J Surg Oncol 1992;18:481-483.
20. Hanssen LE, Lindgren A, Nyrén O: Can endoscopic biopsy specimens be used for reliable Laurén classification of gastric cancer? Scand J Gastroenterol 1996;31:711-715.
21. Lehnert T, Sternberg SS, Sprossmann M, De Cosse JJ: Early gastric cancer. Am J Surg 1989;157:202-207.
22. Rohde H, Koster R, Gebbensleben B, Stutzer H, Rau E: Error of surgical staging in patient with cancer of the stomach. Scand J Gastroneterol 1987;22(suppl 133):27-30.
23. Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Crose N, Leandro Gennari: Total versus subtotal gastrectomy. Surgical morbidity and mortality rates in a multicenter Italian randomized trial. Ann Surg 1997;226:613-620.
24. Meyer HJ, Jaehne J, Pichlmayr R: Surgical treatment of gastric cancer. Sem Surg Oncol 1991;7:356-364.
25. Sue-Ling HM: Radical surgery is essential for treating gastric cancer. Eur J Surg Oncol 1994;20:179-182.
26. Gennari L, Bozzetti F, Bonfanti G, et al. Subtotal versus total gastrectomy in cancer of the lower two-thirds of the stomach: A new approach to an old problem. Br J Surg 1986;73:534-538.
27. Davies J, Johnston D, Sue-Ling H, Young S, May J, Griffith J, Miller G, Martin I: Total or subtotal gastrectomy for gastric carcinoma? World J Surg 1998;22:1048-1055.
28. Gouzi JL, Huguier M, Fagniez PL, Launois B, Flamant Y, Lacaine F, Paquet JC, Hay JM: Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A french prospective controlled study. Ann Surg 1989;209:162-166.
29. Schmidt-Matthiesen A, Beyer PA: Zuverlässigkeit der intraoperativ-makroskopischen Evaluation der Lymphknotenmetastasierung und der Effektivität der Lymphadenektomie beim Magencarcinom. Zentralbl Chir 1996;121:121-125.
30. Jaehne J, Maschek H, Meyer HJ, Pichlmayr R: Systematische Lymphadenektomie beim Magencarcinom - Staging und Therapie. Zentralbl Chir 1996;121:126-130.
31. Keller E für die deutsche kooperative Studien-gruppe TNM beim Magencarcinom: Vorteile des Lymphknotenstagings bei 872 Magencarcinompatienten. Zentralbl Chir 1996;121:139-143.
32. Catarci M, Guadagni S, Zaraca F, Pistoia MA, Mastracchio A, Trecca A, Ruco L, Carboni M: Prospective randomized evaluation of preoperative endoscopie vital staining using CH-40 for lymph node dissection in gastric cancer. Ann Surg Oncol 1998;5:580-584.
33. Japanese Research Society for Gastric Cancer: Allgemeine Richtlinien für Chirurgie und Pathologie der japanischen Magencarcinomstudie. Chirurg 1985;58:539-552.
34. Adachi Y, Ohsiro T, Okuyama T, Kamakura T, Mori M, Maehara Y, Sugimachi K: A simple classification of lymph node level in gastric carcinoma. Am J Surg 1995;169:382-385.
35. Songun I, Bonenkamp JJ, Sasako M, Bunt AMG, Hermans J, van de Velde CJH: Current status of randomized studies about the extent of lymph node dissection. Dig Surg 1994;11:86-92.
36. Yu W, Choi GS, Whang I, Suh IS: Comparison of five systems for staging lymph node metastasis in gastric cancer. Br J Surg 1997;84:1305-1309.
37. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K: Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg 1995;19:532-536.
38. Böttcher K, Becker K, Busch R, Roder JD, Siewert JR: Prognosefaktoren beim Magencarcinom. Ergebnisse einer uni-und multivariaten Analyse. Chirurg 1992;63:656-651.
39. Hüscher C, Chiodini S, Freni V, Recher A, Torri F, Bozzetti F: Adequacy of paracardial dissection in subtotal versus total gastrectomy. Br J Surg 1992;79:942-944.
40. Candela FC, Urmacher C, Brennan MF: Comparison of the conventional method of lymph node staining with a comprehensive fat-clearing method for gastric cancer. Cancer 1990;66:1828-1832.
41. Gardovskis J, Horstmann O, Ohmann C, Verreet PR, Yang Q, Wlasak R, Bösing N, Borchard F, Röher HD: Prognostische Faktoren beim kurativ resezierten Magencarcinom. Eine univariate und multivariate Analyse. Langenbecks Arch Chir 1995;380:75-81.
42. Okusa T, Nakane Y, Boku T, Takada H, Yamamura M, Hioki K, Yamamoto M: Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg Gynecol Obstet 1990;170:488-494.
43. Wittekind C, Wagner G (eds): UICC-TNM-Klassifikation maligner Tumoren; Aufl. 5. Berlin, Springer, 1997.
44. Mendes de Almeida JC, Limbert M, Mendes de Almeida JM: Does the new TNM classification (1997) improve prognostic stratification in gastric cancer submitted to RO surgery. Eur J Surg Oncol 1999;25:280-283.
45. Giles GR: Staging and prognostic determinations of gastric cancer; in Preece PE, Cuschieri A, Wellwood (eds): Cancer of the Stomach. London, Grune and Stratton, 1986, pp 89-105.
46. Volpe CM, Koo J, Miloro SM, Driscoll D, Nava HR, Douglass HO Jr: The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma. J Am Coll Surg 1995;181:56-64.
47. Böttcher K, Roder JR, Siewert JR: Wertigkeit der radikalen Lymphknotendissektion (Compartment I und II) beim Magencarcinom. Zentralblatt Chir 1996;121:131-138.
48. Padberg WM, Doerr U, Buhr J, Kelm C, Henneking K: Die Bedeutung der systematischen Lymphadenektomie beim Magencarcinom. Zentralbl Chir 1996;121:116-120.
49. Wanebo HJ, Kennedy BJ, Winchester DP, Fremgen A, Stewart AK: Gastric carcinoma: Does lymph node dissection alter survival? J Am Coll Surg 1996;183:616-624.
50. Dent DM, Madden MV, Price SK: Randomized comparison of R1 and R2 gastrectomy for gastric cancer. Br J Surg 1988;75:110-112.
51. Robertson CS, Chung SCS, Woods SDS, Griffin SM, Raimes SA, Lau JTF, Li AKC: A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994;220:176-182.
52. Cushieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P for the Surgical Cooperative Group: Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial. Lancet 1996; 347:995-999.
53. Cushieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P for the Surgical Cooperative Groupe: Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomised surgical trial. Br J Cancer 1999;79:1522-1530.
54. Bonenkamp JJ, Hermans J, Sasako M, van de Velde for the Dutch Gastric Cancer Group: Extended lymph-node dissection for gastric cancer. N Engl J Med 1999;340:908-914.
55. Jakab F, Baranyai L, Baranyai Z, Országh A, Mayer Á, Bajtai A: Lymphadenectomy in gastrointestinal surgery for malignancy. Acta Chir Hung 1997;36:141-142.
56. Adachi Y, Mimori K, Mori M, Maehara Y, Sugimachi K: Morbidity after D2 and D3 gastrectomy for node-positive gastric carcinoma. J Am Coll Surg 1997;184:240-244.
57. Whiting JL, Fielding JWL: D1 versis D2 lymph node dissection: Results of the Medical Research Council and Dutch Trial. Chir Gastroenterol 1999;15:244-248.
58. Allgayer H, Heiss M, Schildberg FW: Prognostic factors in gastric cancer. Br J Surg 1997;84:1651-1664.